Bio/Healthcare Ventures 2017
Language:
Japanese
Product Code No:
C59107700
Issued In:
2017/06
#of Pages:
249
Publication Cycle:
Annual
Format:
PDF
Geographic Coverage:
Japan
Industry:
Jump to the Japanese Page:
Coverage: (Product/service)
Bio/Healthcare Ventures (industry-university collaboration, bio/healthcare industrial clusters included) bio/healthcare venture capital/fund
Research Target:
Bio healthcare ventures (derived from pharmaceutical companies, medical equipment companies, university-originated ventures), METI, MEXT, and the Ministry of Health, Labour and Welfare
Research Content:
I Current Status and Perspectives of Bio/Healthcare Ventures
- Recent Trends regarding Bio/Healthcare Ventures
- Changes in roles of bio-healthcare ventures in the life science industry
- Challenges toward development of life science industry
- Trend of ventures from universities
- Bio/healthcare ventures from aspect of pharmaceutical companies
- Business expansion in the realm of bio-healthcare ventures
- Establishment and Operation of Bio/Healthcare Ventures
- Patterns of education and generation
- Fundraising
- Securing man power
- Patent strategies
- Business alignment
- Initial Public Offering
- Exit strategy
- Market Environment surrounding Life Science Industry and Ventures
- National Policies regarding life science
- Bio Business Strategies at Bio/Healthcare Market Players
- Bio business strategies at pharmaceutical companies
- Bio business strategies at medical device related (tests, diagnosis, treatment) companies
- Governmental Support (Subsidies, Promotions) to Ventures
- Status of "Approved TLOs"
- Status of Industry-University Collaboration
- Status of University-Originated Ventures
- Status of Bio/Healthcare Industrial Clusters
- Bio/Healthcare Venture Market Structure
II Business Status of Bio/Healthcare Ventures (Analysis from Questionnaire)
- Survey Overview
- Attributes of Responded Companies
- Business Category, Details
- Target Diseases
- Development Status by Stage
- Status of Intellectual Properties
- Exit Strategy
- Support Status from External Institutions
- Changes in Business Environment
- In-house Challenges
- Noteworthy Enterprises
- Entire Industry in the Future
III Business Strategies by Bio/Healthcare Ventures
12 Ventures
IV List of 686 Bio/Healthcare Ventures